Efficacy of danofloxacin in the treatment of respiratory disease in European cattle

Veterinary Record

Volumn 154, Issue 19, 2004, Pages 585-589

  Rowan, T G ^a   Sarasola, P ^b   Sunderland, S J ^a   Giles, C J ^c   Smith, D G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Ondax Scientific   (Spain)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANOFLOXACIN; TILMICOSIN;

ARTICLE; BACTERIUM ISOLATION; BREATHING DISORDER; CATTLE DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EUROPE; FRANCE; HISTOPHILUS SOMNI; IRELAND; MANNHEIMIA HAEMOLYTICA; NONHUMAN; NOSE SMEAR; PASTEURELLA MULTOCIDA; RECTUM TEMPERATURE; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; THROAT CULTURE; TREATMENT OUTCOME; UNITED KINGDOM;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; HAEMOPHILUS; HISTOPHILUS SOMNI; MANNHEIMIA; MANNHEIMIA HAEMOLYTICA; PASTEURELLA; PASTEURELLA MULTOCIDA;

EID: 2542506378     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.154.19.585     Document Type: Article

References (25)

1. ANON (1994a) Good Clinical Practice for the Conduct of Clinical Trials for Veterinary Medicinal Products (GCPV) - The EU Note for Guidance. European Union Committee for Veterinary Medicinal Products. Brussels, Belgium, FEDESA
2. ANON (1994b) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Proposed Standard. Doc M31-P (Vol 14, number 20, 12/94). Wayne, National Committee of Clinical Laboratory Standards
3. AGRESTI,A. (1990) Categorical Data Analysis. New York, John Wiley and Sons. p 395
4. AMES, T. R. (1997) Dairy calf pneumonia: the disease and its impact. Veterinary Clinics of North America: Food Animal Practice 13, 379-391
5. APLEY, M. D. & UPSON, D. W. (1993a) Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia. American Journal of Veterinary Research 54, 937-943
6. APLEY, M. D. & UPSON, D. W. (1993b) Regional danofloxacin lung tissue concentrations and their relationship to regional pulmonary blood flow in consolidated and non-consolidated bovine lung. American Journal of Veterinary Research 54, 944-951
7. BROWN, S. A. (1996) Flouroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics 19, 1-14
8. BRYSON D. G. (1985) Calf pneumonia. Veterinary Clinics of North America: Food Animal Practice 1, 237-257
9. DEROSA, D. C., MECHOR, G. D., STAATS, J. J., CHENGAPPA, M. M. & SHYROCK, T. R. (2000) Comparison of Pasteurella spp simultaneously isolated from nasal and transtracheal swabs from cattle with clinical signs of bovine respiratory disease. Journal of Clinical Microbiology 38, 327-332
10. DRUSANO, G. L., JOHNSON, D. E., ROSEN, M. & STANDIFORD, H. C. (1993) Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrobial Agents and Chemotherapy 37, 483-490
11. FODOR, L., VARGA, J., GALLOWITSCH, F., HORVÁTH-PAPP, I., MIKLÓS, G., LAJCSÁK, A. & HARMATH, A. (1993) Treatment of calf pneumonia with tilmicosin. Acta Veterinaria Hungarica 41, 41-49
12. FORREST, A., NIX, D. E., BALLOW, C. H., GOSS, T. F., BIRMINGHAM, M. C. & SCHENTAG, J. J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy 37, 1073-1081
13. FRIIS, C. (1993) Penetration of danofloxacin into the respiratory tract tissues and secretions in calves. American Journal of Veterinary Research 54, 1122-1127
14. GILES, C. J., GRIMSHAW, W. T. R., SHANKS, D. J. & SMITH, D. G. (1991a) Efficacy of danofloxacin in the therapy of acute bacterial pneumonia in housed beef cattle. Veterinary Record 128, 296-300
15. GILES, C. J., MAGONIGLE, R. A., GRIMSHAW, W. T. R., TANNER, A. C., RISK, J. E., LYNCH, M. J. & RICE, J. R. (1991b) Clinical pharmacokinetics of parenterally administered danofloxacin in cattle. Journal of Veterinary Pharmacology and Therapeutics 14, 400-410
16. GRIMSHAW, W. T. R., GILES, C. J., COOPER, A. C. & SHANKS, D. J. (1990) The efficacy of danofloxacin in the therapy of pneumonia associated with Pasteurella species in housed calves. Deutsche Tierärztliche Wochenschrift 97, 529-532
17. KNOWLES, T. G. (1995) A review of post transport mortality among younger calves. Veterinary Record 137, 406-407
18. LAVEN, R. & ANDREWS, A. H. (1991) Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracycline. Veterinary Record 129, 109-111
19. LINDECRONA, R. H., FRIIS, C. & JENSEN, N. E. (1999) The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in-vitro pharmacodynamic model. Research in Veterinary Science 67,93-97
20. MEINEN, J. B., MCCLURE, J. T. & ROSIN, E. (1995) Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections. American Journal of Veterinary Research 56, 1219-1224
21. OSE, E. E. & TONKINSON, L. V. (1988) Single-dose treatment of neonatal calf pneumonia with the new macrolide antibiotic tilmicosin. Veterinary Record 123, 367-369
22. PICAVET, T., MUYLLE, E., DEVRIESE, L. A. & GERYL, J. (1991) Efficacy of tilmicosin in treatment of pulmonary infections in calves. Veterinary Record 128, 400-403
23. PICKERILL, K. E., PALADINO, J. A. & SCHENTAG, J. J. (2000) Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy 20, 417-428
24. ROE, C. P. (1982) A review of the environmental factors influencing calf respiratory disease. Agricultural Meteorology 26, 127-144
25. SARASOLA, P., LEES, P., ALIABADI, F. S., MCKELLAR, Q. A., DONACHIE, W., MARR, K. A., SUNDERLAND, S. J. & ROWAN, T. G. (2002) Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica. Antimicrobial Agents and Chemotherapy 46, 3013-3019